The Trump administration is weighing measures that would make it more expensive for pharmaceutical companies to conduct ...

Following a disappointing performance from the company’s CAR-T candidate in an early-stage cancer trial, BioNTech is winding down cell therapy manufacturing at its inaugural U.S. plant. | Following a ...

Two Democratic lawmakers have renewed accusations that large pharma companies have evaded paying U.S. taxes through a ...

Following HHS secretary Robert F. Kennedy Jr.’s decision last week to purge the CDC’s Advisory Committee on Immunization ...

June, advertising agencies that work behind the scenes to execute drug ads are rewarded with their moment in the spotlight as ...